3669 results for «300»

Filter By

3669 results

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

21 Nov 2021 – From PCR London Valves

Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.

PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

22 Nov 2021 – From PCR London Valves

Watch this session broadcast at PCR London Valves 2021 to find out more about TMVR as a novel treatment option for patients with mitral disease, to learn how to identify the right candidate for TMVR, and to understand how to best medically manage patients peri-procedurally.

Transcatheter mitral valve replacement: patient selection and hemodynamic stability

Obtaining commissural alignment in TAVI

23 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.

Obtaining commissural

Lifetime management of patients with severe aortic stenosis

22 Nov 2021 – From PCR London Valves

Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...

Lifetime management of patients with severe aortic stenosis

Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis

21 Nov 2021 – From PCR London Valves 2021

Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.

Predictability at release

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

23 Nov 2021 – From PCR London Valves

Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...

Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform

EAPCI: patient initiatives around the world

22 Nov 2021 – From PCR London Valves 2021

In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.

EAPCI:  patient initiatives around the world

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options

21 Nov 2021 – From PCR London Valves 2021

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...

From TAVI to mitral and

From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure

21 Nov 2021 – From PCR London Valves

In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...

From TAVI to mitral and tricuspid - Part 1 - Best long-term outcomes start with the first procedure

From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options

22 Nov 2021 – From PCR London Valves

Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...

From TAVI to mitral and tricupid - Part 2 - Securing long-term patient options

Innovation and imaging guidance for tricuspid valve replacement

21 Nov 2021 – From PCR London Valves

Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.

Innovation and imaging guidance for tricuspid valve replacement

HighLife TSMVR study status and new developments

22 Nov 2021 – From PCR London Valves 2021

Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...

HighLife TSMVR study status and new developments

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

22 Nov 2021 – From PCR London Valves

Watch this session released during PCR London Valves 2021 Congress to have a deep dive into aortic regurgitation: the natural history, the clinical reality of it, and a fantastic live recorded case, so as to gain deeper understanding of the progression of severe aortic regurgitation, to learn more...

A new evolution: TAVR for aortic regurgitation with the JenaValve Trilogy System

Intrepid early experience

23 Nov 2021 – From PCR London Valves 2021

This session of PCR London Valves 2021 needs to be watched to learn more about Medtronic's mitral and tricuspid clinical trial updates, better understand treatable anatomies for TMVR, and gain awareness on early feasibility Intrepid data.

Intrepid early experience

Practical solutions to grow your TAVI programme - peer-to-peer case sharing

23 Nov 2021 – From PCR London Valves 2021

Thanks to this PCR London Valves 2021 session, explore real-world examples of how to use digital communication successfully with your referral network, discover practical ways to implement a TAVI nurse programme in your hospital and learn how to obtain resources and support from your hospital management...

Practical solutions to grow your TAVI programme - peer-to-peer case sharing

Procedural aspects of TAVI patient long-term management

22 Nov 2021 – From PCR London Valves 2021

At the PCR London Valves 2021 Congress, a session was proposed to discuss long-term management of TAVI patients: gain knowledge in procedural PCI access after TAVI through case examples, and learn more about the essential steps of the cusp overlap implantation technique by watching it now!

Procedural aspects of TAVI patient long-term management

SURTAVI five-year outcomes - What do you need to know considering the new ESC guidelines?

21 Nov 2021 – From PCR London Valves 2021

Join Nicolas Van Mieghem, Nicole Karam and Thomas Modine to learn more about about SURTAVI five-year study outcomes and to discover which factors are impacting valve performance overtime.

SURTAVI five-year outcomes

Cusp overlap technique - How it evolved my practice?

21 Nov 2021 – From PCR London Valves 2021

Join Darren Mylotte, Derk Frank and Vincent Roolvink if you want to discover real-life practices with the Cusp Overlap technique, as well as to learn about its adoption benefits and its essentials procedural steps.

Cusp overlap technique

Lean TAVI: safe efficiencies and better economics

21 Nov 2021 – From PCR London Valves 2021

Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...

Lean TAVI: safe efficiencies

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice

21 Nov 2021 – From PCR London Valves 2021

Join Raúl Moreno, Julian Widder and Mathias Wolfrum  if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.

The uncompromised hemodynamics
Didn’t find what you were looking for?